General Information of Drug (ID: DMOWM9H)

Drug Name
Mesenchymal stromal cells
Indication
Disease Entry ICD 11 Status REF
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
D00UKN

References

1 ClinicalTrials.gov (NCT04366271) Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19. U.S. National Institutes of Health.